Abstract

BackgroundThe secondary use of clinical data in data-gathering, non-interventional research or learning activities (SeConts) has great potential for scientific progress and health care improvement. At the same time, it poses relevant risks for the privacy and informational self-determination of patients whose data are used.ObjectiveSince the current literature lacks a tailored framework for risk assessment in SeConts as well as a clarification of the concept and practical scope of SeConts, we aim to fill this gap.MethodsIn this study, we analyze each element of the concept of SeConts to provide a synthetic definition, investigate the practical relevance and scope of SeConts through a literature review, and operationalize the widespread definition of risk (as a harmful event of a certain magnitude that occurs with a certain probability) to conduct a tailored analysis of privacy risk factors typically implied in SeConts.ResultsWe offer a conceptual clarification and definition of SeConts and provide a list of types of research and learning activities that can be subsumed under the definition of SeConts. We also offer a proposal for the classification of SeConts types into the categories non-interventional (observational) clinical research, quality control and improvement, or public health research. In addition, we provide a list of risk factors that determine the probability or magnitude of harm implied in SeConts. The risk factors provide a framework for assessing the privacy-related risks for patients implied in SeConts. We illustrate the use of risk assessment by applying it to a concrete example.ConclusionsIn the future, research ethics committees and data use and access committees will be able to rely on and apply the framework offered here when reviewing projects of secondary use of clinical data for learning and research purposes.

Highlights

  • The secondary use of clinical data for research purposes is increasingly recognized as a promising and crucial tool for improving health care and advancing medical research

  • These types of research or learning activities were inferred from a scoping review (a), in which we searched PubMed and Google Scholar between October and November 2019 for bioethical literature that deals with the expected risks and benefits of secondary use of clinical data for biomedical research

  • If secondary use of clinical data was to be implemented in the future as a standard in the health care system, this could lead to a tendency to collect data more systematically or collect more data than necessary in the care context, thereby blurring the distinction between data generation for care and data generation for research

Read more

Summary

Introduction

The secondary use of clinical data for research purposes is increasingly recognized as a promising and crucial tool for improving health care and advancing medical research. Several initiatives strive to use data from medical care for secondary research and learning activities [1]. There are numerous advantages of the secondary use of clinical data (ie, data derived from patient care) for research and learning activities. Large sample sizes can be obtained by aggregating the data from different sites This benefits research on rare diseases [7]. Patients can contribute their clinical data to research or learning activities without being exposed to immediate physical risks [5]. The secondary use of clinical data in data-gathering, non-interventional research or learning activities (SeConts) has great potential for scientific progress and health care improvement. It poses relevant risks for the privacy and informational self-determination of patients whose data are used

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.